FDA Inspection 776388 — Anthony Dugard
The FDA completed an inspection of Anthony Dugard on March 23, 2012 in Limoges Cedex 1. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Limoges Cedex 1 (France)
Additional Details
Clinical Investigator (CI)